wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q56986459-00742D25-2D44-44BE-81CC-DB116C6CE69C
Q56986459-00742D25-2D44-44BE-81CC-DB116C6CE69C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56986459-00742D25-2D44-44BE-81CC-DB116C6CE69C
The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF
P2860
Q56986459-00742D25-2D44-44BE-81CC-DB116C6CE69C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56986459-00742D25-2D44-44BE-81CC-DB116C6CE69C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb093daee773c90551dc1449ddfa4e89f5cbcc52
P2860
A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma.